Wordt geladen...
MYL1501D Insulin Glargine: A Review in Diabetes Mellitus
Subcutaneous MYL1501D insulin glargine 100 U/mL (hereafter referred to as MYL1501D insulin glargine) [Semglee(®)] is a long-acting human insulin analogue approved as a biosimilar of insulin glargine 100 U/mL (hereafter referred to as reference insulin glargine 100 U/mL) [Lantus(®)] in various countr...
Bewaard in:
| Gepubliceerd in: | BioDrugs |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer International Publishing
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7217807/ https://ncbi.nlm.nih.gov/pubmed/32215829 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-020-00418-x |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|